key: cord-0899638-803ygxhd authors: Ahammed, T.; Anjum, A.; Rahman, M. M.; Haider, N.; Kock, R.; Uddin, M. J. title: Estimation of novel coronavirus (covid-19) reproduction number and case fatality rate: a systematic review and meta-analysis date: 2020-09-30 journal: nan DOI: 10.1101/2020.09.30.20204644 sha: c01a4e4c22cdabc1551a4b600354ac9287517a42 doc_id: 899638 cord_uid: 803ygxhd Understanding the transmission dynamics and the severity of the novel coronavirus disease 2019 (COVID-19) informs public health interventions, surveillance, and planning. Two important parameters, the basic reproduction number (R0) and case fatality rate (CFR) of COVID-19, help in this understanding process. The objective of this study was to estimate the R0 and CFR of COVID-19 and assess whether the parameters vary in different regions of the world. We carried out a systematic review to retrieve the published estimates of the R0 and the CFR in articles from international databases between 1st January and 31st August 2020. Random-effect models and Forest plots were implemented to evaluate the mean effect size of the R0 and the CFR. Furthermore, the R0 and CFR of the studies were quantified based on geographic location, the tests/thousand population, and the median population age of the countries where studies were conducted. The I2 statistic and the Cochran's Q test were applied to assess statistical heterogeneity among the selected studies. Forty-five studies involving R0 and thirty-four studies involving CFR were included. The pooled estimation of the R0 was 2.69 (95% CI: 2.40, 2.98), and that of the CFR was 2.67 (2.25, 3.13). The CFR in different regions of the world varied significantly, from 2.51 (2.12, 2.95) in Asia to 7.11 (6.38, 7.91) in Africa. We observed higher mean CFR values for the countries with lower tests (3.15 vs. 2.16) and greater median population age (3.13 vs. 2.27). However, the R0 did not vary significantly in different regions of the world. An R0 of 2.69 and CFR of 2.67 indicate the severity of the COVID-19. Although R0 and CFR may vary over time, space, and demographics, we recommend considering these figures in control and prevention measures. Since the emergence of SARS-CoV-2, the virus causing COVID- 19 Another important factor to inform is the case fatality rate (CFR), which is the proportion of deaths compared to the total number of people diagnosed with a disease within a defined population of interest and is typically presented as a percentage [4] . CFR is an indicator of disease severity and can be used to identify high-risk populations to inform targeted interventions and the overall public health response [5] . To understand the transmissibility and severity of SARS-CoV-2 in populations, there have been several estimates of R0 and the CFR. Estimates of R0 and CFR have varied in different countries and different settings [6] . For example, in the Diamond Princess cruise ship, the estimated median R0 was 2.28 (95% CI: 2.06-2.52) [7] . In Wuhan, during the early phase of the outbreak, the R0 was estimated as 2.24 (95% CI: 1.96-2.55) [8] . The R0 has also been estimated for several other countries including Italy, 3.2 (95% CI: 2.9-3.5) [9] ; USA, 5.3 (95% CI: 4.35-6.25) [10] ; and, Japan, 2.6 (95% CI: 2.4-2.8) [11] . . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint Likewise, estimates of CFRs have varied in different countries and phases of the pandemic. A study found that at the start of the epidemic, CFR in China was 2%, but on 5 March 2020, it was increased to 3.7%. In South Korea, the same study reported the CFR as 0.6% on 5 March 2020 [12] . In Europe, during March 2020, Italy, Spain, and France had a CFR of 9.26%, 6.16%, and 4.21%, respectively [13] . Given the considerable variation in estimates of both these parameters, in this current study, our aim was to conduct a systematic review and meta-analysis of the published literature on the COVID-19 outbreak to provide summary statistics of the R0 and the CFR, which have the best applicability for other countries or regions. We followed the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2009. We registered the study protocol with the International prospective register of systematic reviews (PROSPERO) (registration number ID: CRD42020182867). We systematically searched the major databases: LitCovid (a curated COVID-19 database of PubMed), PubMed, EMBASE, Scopus, and Web of Science databases from 1 January 2020 to 31 August 2020. We searched articles for "Basic reproduction number (R0)" and "Case-fatality rate (CFR)" of the COVID-19 patients. For basic reproduction number, the search terms were: "2019 novel coronavirus and COVID-19" AND "Basic reproduction number", OR "Basic reproduction rate" OR "R0". For the case fatality rate, the search terms were "2019 novel coronavirus and COVID-19" AND "case fatality rate", OR "case fatality ratio", OR "CFR" according to the indices of the various databases (Supplementary Table S1 ). We also hand . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint for R0 and 34 research articles [13, 15, [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] 24, [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] 55, [82] [83] [84] [85] [56] [57] [58] [59] [60] [61] for CFR estimation were selected. The critical appraisal of each selected study was assessed by TA and AA independently using modified Risk of Bias (ROB) operational criteria (Supplementary Table S2 and Table S3 ) [86] . Publication bias was assessed using a funnel plot, and the Egger's test with P < 0.05 was an indication of small-study effects. We defined R0 as the expected number of cases directly generated by one infected case in a population where all individuals are susceptible and CFR as the percentage of COVID-19 cases that result in death. Background statistics of the COVID-19 patients were recorded through frequency distribution analysis. A random-effect model was, therefore, used to perform a metaanalysis. The geo-location variations for R0 and geo-location, tests per thousand population, and population median age variations for CRF were examined using subgroup analysis. The median values of the frequency distributions were used as cut-off values of the sub-groups. Heterogeneity was assessed among the selected studies using the Higgin's & Thompson's I 2 statistic and Cochran's Q test. All statistical analyses were performed using Stata SE version 16.1 (Stata Corporation, College Station, TX, USA 5. We identified a total of 490 articles estimating R0. After considering the duplicates, inclusion, and exclusion criteria, we reviewed these research articles. We searched for titles, . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint abstracts and keywords, methodology, and references and found 59 articles to investigate further ( Fig. 1) . Out of these 59 articles, we found 45 research articles that reported 108 R0 estimates ranging from 0.27 to 8.21 with related statistics for a meta-analysis (Supplementary Table S4 ). Similarly, for the CFR, after considering filtering criteria, only 34 research articles out of 955 articles qualified for quantifying parameter values of CFR (Fig. 1) , and these 34 articles provided 158 estimates of CFR ranging from 0.00 to 25.9 for use in the meta-analysis (Supplementary Table S5 ). No studies were excluded. In the random-effects model, the pooled R0 for COVID-19 was estimated as 2. 69 (Table 1) . However, the test of regional subgroup differences using the random-effects model confirms that the estimated mean R0 values are not significantly different across these regions (p= 0.43). The Funnel plot for assessing publication bias of R0 values computed from the random-effects model is shown in Fig. 3. This Funnel plot is indicating the existence of asymmetry and publication bias. Additionally, the Egger's test (P < 0.001) suggested the presence of small-study effects. The pooled estimation of the CFR from the random-effects model was 2.67 (2.25, 3.13). There was significant heterogeneity between studies (I 2 : 99.95, Q = 315324.53 with p = 0.00) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. Our estimate of the R0 statistic implies that one infectious person can transmit the infection to more than two and a half susceptible persons in a naïve population in the absence of any control measures. However, the R0 did not vary significantly across the continents. Among these regions, the highest R0 was estimated for 'North America' (3.69) and lowest for 'South America' (2.32). We estimated a CFR of above two and a half, and the CFR varied in different continents (highest 7.11 in Africa, lowest 2.51 in Asia). We further observed lower CFR values . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint of COVID-19 in the countries where a higher number of samples (per thousand population) were tested, and higher CFR values where the median age of the national population was higher (>38.7 years). Our estimated overall R0 is slightly greater than WHO estimates of 1.4 to 2.5 [87] [88, 89] . Our estimation is similar to the R0 values estimated for the severe acute respiratory syndrome epidemic (R0= 2-3) but greater than the Middle East respiratory syndrome in the Middle East (R0 <1) [90] . However, high R0 values tend to be estimated in the early stages of epidemics and pandemics due to small sample sizes and incomplete information. Even if the overall R0 value in a population is low, the likelihood of transmission in some subgroups of that population may still be high as the total value of R0 in a population is the average of the R0 subtypes of that community. Our estimated value for CFR is less than the WHO reported estimate of 3.4% [91] [88] . Our estimated CFR is lower than the CFR values estimated for the other severe coronavirus, severe acute respiratory syndrome epidemic (9.6%), and the Middle East respiratory syndrome (40%) [90] , but higher than that of influenza (0·1%) [93, 94] . While multiple studies reported higher estimates of the case fatality rate than ours, those estimates are typically higher than the actual case fatality rate, as mild, atypical, and asymptomatic cases may not be identified (contrary to deaths), particularly in countries where access to testing is limited [95] . For example, before 11 March 2020 in the USA, sufficient, state-funded testing for all suspected cases was not available [96] . A study with 565 Japanese people who had been evacuated from Wuhan found that the number of infected . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint people is likely to be about ten times greater than the number of registered cases. The CFR would then only be about one-tenth of that currently measured [97] . Our included studies may suffer from bias of these higher numbers of unreported cases, which could increase the pooled CFR estimation. Thus, we further estimated the CFR excluding the extreme values and the naive CFR greater than four. These gave us lower CFR values close to one. In our estimation, the CFR varied among different regions, but the R0 did not vary significantly. We found lower CFR in the countries with a higher number of sample testing per thousand population. A higher number of testing allowed detection of more pre-/a-symptomatic and mild cases, which reduced the rate of fatal outcome [98] . We further found that countries with higher median age had higher CFR value. Older age has been recognized as one of the most common risk factors for a severe outcome of COVID-19 [99] [100] [101] . A study conducted with 5,484 patients in Italy found the CFR of COVID-19 was 0.43% for people below 70 years and 10.5% for people above 70 years and above [101] . Another study showed that an increase of 1% population aged 65 years and above increased the risk of death due to COVID-19 by 10% [100] . An estimate of R0 is affected by several factors, including the proportion of the susceptible population, population density, and awareness among people. Because SARS-COV-2 is a novel virus, we believe the proportion of the susceptible population remains the same across the world; however, other factors (density and awareness) vary. The density of the population is lower in European and North American countries compared with Asian counterparts. Thus, our estimation of the R0 for non-significant variation came as a surprise. However, the early phase of the pandemic produces incomplete data. Further studies on the R0 are essential to understand how different lockdown measures, especially face covering, social distancing, and demographic . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint (population density) and environmental factors (temperature, humidity, UV light), affect the transmission dynamic of SARS-CoV-2 [102] [103] [104] [105] . For developing and populated countries, the R0 value of 2.69 indicates the rapid spread of the COVID-19, and the CFR value of 2.67 is an indication of a relatively poor outcome of the treatments. Necessary precautions and strategies such as preventing mass gatherings, restricting the transportation system, and closing schools and universities should continue to prevent the outbreak of this disease until a successful vaccine arrived. Some of the included studies were limited in terms of sample size, missing information on the onset of COVID-19, and data availability. Therefore, the reported findings should be interpreted cautiously within that context. Furthermore, our study was limited to the articles published in the English language only. Considering the epicenter of COVID-19, Chinese literature should be included in future systematic reviews. Another important limitation is the case detection and testing heterogeneity. Countries' responses varied, and some countries are facing difficulties in testing enough samples. Further, the quality of the testing samples also varies in different countries. All these have affected the case detection and thus impacted the R0 and CFR. However, we believe the effects are minimum, and data across the world are still comparable. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. None. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint Fig. 3 . Funnel plot for the basic reproduction number (R0) values based on the random-effects model. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint Fig. 4 . Forest plot of the case fatality rate (CFR) values based on the random-effects model. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 30, 2020. . https://doi.org/10.1101/2020.09.30.20204644 doi: medRxiv preprint Estimating Absolute and Relative Case Fatality Ratios from Infectious Disease Surveillance Data Analysis and forecast of COVID-19 spreading in China Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A datadriven analysis in the early phase of the outbreak Preliminary estimates of the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 Outbreak dynamics of COVID-19 in China and the United States Prediction of the Epidemic Peak of Coronavirus Disease in Japan, 2020 Is Coronavirus disease (COVID-19) case fatality ratio underestimated? Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2 Early Transmission Dynamics of Novel Coronavirus (COVID-19) in Nigeria Data-based analysis, modelling and forecasting of the COVID-19 outbreak Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China Estimating the reproductive number and the outbreak size of COVID-19 in Korea Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases Early dynamics of transmission and control of COVID-19: a mathematical modelling study Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Pattern of early human-to-human transmission of Wuhan Tracing DAY-ZERO and Forecasting the Fade out of the COVID-19 Outbreak in Lombardy, Italy: A Compartmental Modelling and Numerical Optimization Approach High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission potential and severity of COVID-19 in South Korea The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China Estimation of Unreported Novel Coronavirus (SARS-CoV-2) Infections from Reported Deaths: A Susceptible-Exposed-Infectious-Recovered-Dead Model Effect of a wet market on coronavirus disease (COVID-19) transmission dynamics in China TRANSMISSION DYNAMICS AND CONTROL STRATEGIES OF COVID-19 IN WUHAN When will the battle against novel coronavirus end in Wuhan: A SEIR modeling analysis Current trends and future prediction of novel coronavirus disease (COVID-19) epidemic in China: a dynamical modeling analysis Estimating the serial interval of the novel coronavirus disease (COVID-19) based on the public surveillance data in Shenzhen Evaluating Transmission Heterogeneity and Super-Spreading Event of COVID-19 in a Metropolis of China Analysis of the Transmissibility Change of 2019-Novel Coronavirus Pneumonia and Its Potential Factors in China from Forecast Possible Risk for COVID-19 Epidemic Dissemination Under Current Control Strategies in Japan The basic reproduction number and prediction of the epidemic size of the novel coronavirus Impact of nonpharmacological interventions on COVID-19 transmission dynamics in India Assessment of lockdown effect in some states and overall India: A predictive mathematical study on COVID-19 outbreak Estimation of reproduction numbers of COVID-19 in typical countries and epidemic trends under different prevention and control scenarios Is Nigeria really on top of COVID-19? Message from effective reproduction number Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies Phase-adjusted estimation of the COVID-19 outbreak in South Korea under multi-source data and adjustment measures: a modelling study Modelling the effects of media coverage and quarantine on the COVID-19 infections in the UK The reproduction number of COVID-19 and its correlation with public health interventions Estimates of the ongoing need for social distancing and control measures post-"lockdown" from trajectories of COVID-19 cases and mortality Early transmission dynamics of COVID-19 in a southern hemisphere setting COVID-19 in a designated infectious diseases hospital outside Hubei Province Understanding epidemic data and statistics: A case study of COVID-19 Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment Preparedness is Essential for Western Pacific Islands During the COVID-19 Estimating the instant case fatality rate of COVID-19 in China Preliminary Estimate of COVID-19 Case Fatality Rate in the Philippines using Linear Regression Analysis Estimating risk for death from coronavirus disease, China Case Fatality Rate estimation of COVID-19 for European Countries: Turkey's Current Scenario Amidst a Global Pandemic; Comparison of Outbreakswith European Countries Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship Estimates of the severity of coronavirus disease 2019: a model-based analysis Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis Monitoring transmissibility and mortality of COVID-19 in Europe Epidemic Trend of COVID-19 Transmission in India During Lockdown-1 Epidemiological Characteristics and Forecast of COVID-19 Outbreak in the Republic of Kazakhstan Global Epidemiology of First 90 Days into COVID-19 Pandemic: Disease Incidence, Prevalence, Case Fatality Rate and Their Association with Population Density, Urbanisation and Elderly Population COVID-19 Trends and Forecast in the Eastern Mediterranean Region With a Particular Focus on Pakistan Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States Risk of death by age and gender from CoVID-19 in Peru Is Colombia an example of successful containment of the COVID-19 2020 pandemic? A critical analysis of the epidemiological data IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe High altitude reduces infection rate of COVID-19 but not case-fatality rate Age-dependent gender differences of COVID-19 in mainland China: comparative study Estimating the Risk of COVID-19 Death During the Course of the Outbreak in Korea Epidemiology of the 2020 Pandemic of COVID-19 in the State of Environmental Temperature on the Attack rate and Case fatality rate of Coronavirus Disease 2019 (COVID-19) Pandemic Epidemiology of COVID-19 Infection in Oman: Analysis of the First 1304 Cases Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement The reproductive number of COVID-19 is higher compared to SARS coronavirus Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis Estimate of the Basic Reproduction Number for COVID-19: A Systematic Review and Meta-analysis MERS--an uncertain future WHO Director-General's opening remarks at the media briefing on COVID-19 -3 Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China SARS and MERS: Recent insights into emerging coronaviruses Covid-19 -Navigating the uncharted German Network for Evidence-based Medicine. COVID-19: Where's the evidence The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights Covid-19 mortality is negatively associated with test number and government effectiveness COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors Will Coronavirus Pandemic Diminish by Summer? Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? Seasonal immunity: Activity of thousands of genes differs from winter to summer Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study